Epitopea
Latest round
- Seed
Last raised
- Apr 2022
Total raised
- $13M
Investors
- 6
About Epitopea
Based in Cambridge, UK, and founded in 2021 by Dr. Claude Perreault and Dr. Pierre Thibault and headed by John Moore as CEO, Epitopea Limited also known as Epitopea is an organization that is engaged in the research and development of cancer immunotherapies. The company has offices in Montreal, Canada, and Cambridge, UK.TSAs.TSAs, which can be utilized as potential targets that allow drugs to destroy and eliminate malignant or cancerous cells, without affecting the non-malignant cells.
Who invested in Epitopea
6 investors across 1 round
See all investors in Epitopea
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 25, 2022
Amount
$13M
Investors
Questions about Epitopea
Who invested in Epitopea?
Epitopea has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Epitopea raised?
Epitopea has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Epitopea last raise money?
Epitopea's most recent round on record is a Seed, in Apr 2022.
What does Epitopea do?
Based in Cambridge, UK, and founded in 2021 by Dr.
Where is Epitopea headquartered?
Epitopea is headquartered in Cambridge, UK.
Which VCs invest in companies like Epitopea?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Epitopea's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Epitopea? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.